Summary:
Phase III study of an investigational medication for depression.
Qualified Participants Must:
• Be 18-65 years of age
•
Be experiencing symptoms of depression
•
Have previously been treated for depression
•
Be willing to attend all study visits
Qualified Participants May Receive:
Study related medical exams and medication and compensation for time and travel.